Normal Saline 0.9% Infusion Solution — Competitive Intelligence Brief

Normal Saline 0.9% Infusion Solution (Normal Saline 0.9% Infusion Solution) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Crystalloid fluid / Electrolyte replacement solution. Area: Supportive Care / Fluid Management.

phase 3 Crystalloid fluid / Electrolyte replacement solution Supportive Care / Fluid Management Small molecule

Target snapshot

Normal Saline 0.9% Infusion Solution (Normal Saline 0.9% Infusion Solution) — Fayoum University Hospital. Normal saline restores and maintains fluid and electrolyte balance by providing isotonic sodium chloride solution for intravenous administration.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Normal Saline 0.9% Infusion Solution TARGET	Normal Saline 0.9% Infusion Solution	Fayoum University Hospital	phase 3	Crystalloid fluid / Electrolyte replacement solution
Normal Saline 0.9% Infusion Solution Bag	Normal Saline 0.9% Infusion Solution Bag	Vanderbilt University Medical Center	marketed	Crystalloid fluid / Electrolyte replacement solution
Sodium Chloride 0.9% infusion	Sodium Chloride 0.9% infusion	Hospital Central "Dr. Ignacio Morones Prieto"	marketed	Crystalloid fluid / Electrolyte replacement solution
saline 09%	saline 09%	Vinmec Healthcare System	marketed	Crystalloid fluid / Electrolyte replacement solution
Isotonic NaCl	Isotonic NaCl	Hvidovre University Hospital	marketed	Crystalloid fluid / Electrolyte replacement solution
Sterile isotonic saline solution	Sterile isotonic saline solution	Hospital Italiano de Buenos Aires	marketed	Crystalloid fluid / Electrolyte replacement solution
Isotonic sodium chloride 0.9 percent	Isotonic sodium chloride 0.9 percent	Rigshospitalet, Denmark	marketed	Crystalloid fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Crystalloid fluid / Electrolyte replacement solution class)

1. Dr. Waseem Ullah · 1 drug in this class
2. Fayoum University Hospital · 1 drug in this class
3. GCP-Service International West GmbH · 1 drug in this class
4. Hospital Central "Dr. Ignacio Morones Prieto" · 1 drug in this class
5. Hospital Italiano de Buenos Aires · 1 drug in this class
6. Hvidovre University Hospital · 1 drug in this class
7. Hédi Chaker Hospital · 1 drug in this class
8. Kecioren Education and Training Hospital · 1 drug in this class
9. Krankenhaus Barmherzige Schwestern Linz · 1 drug in this class
10. London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 1 drug in this class